Article
HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype.
American journal of respiratory and critical care medicine - 1 May 1999
Aron Y, Polla B S, Bienvenu T, Dall'ava J, Dusser D, Hubert D
Abstract excerpt
Evolution of lung damage is highly variable in cystic fibrosis (CF) even in patients with the same cystic fibrosis transmembrane conductance regulator (CFTR) mutations. The analysis of genetic factors other than CFTR may help our understanding of genotype-phenotype relationships in CF. As human leukocyte antigen (HLA) class II polymorphism has been associated with a number of diseases including autoimmune and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
